Jump Financial, LLC Igm Biosciences, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.28 - $17.68 $120,576 - $339,456	-19,200 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $124,992 - $220,224	19,200 New	19,200 $131,000
Q2 2023 Oct 21, 2024	BUY	$8.86 - $14.0 $5,165 - $8,162	583 Added 3.04%	19,783 $182,000
Q2 2023 Aug 07, 2023	BUY	$8.86 - $14.0 $175,277 - $276,962	19,783 New	19,783 $182,000
Q3 2022 Nov 07, 2022	BUY	$15.42 - $27.01 $12,968 - $22,715	841 Added 3.23%	26,900 $612,000
Q2 2022 Aug 09, 2022	BUY	$13.27 - $25.5 $345,802 - $664,504	26,059 New	26,059 $470,000

20.7M

68K

52.2K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $214M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.